NEOGEN quarterly results and annual financials: sales, operating profit, OPM, net profit, EPS, balance sheet, cash flow and ratios like ROCE, with YoY and QoQ growth.
Neogen Chemicals Ltd reported sales of ₹295.96 Cr, operating profit of ₹45.32 Cr (OPM 15.31%) and net profit of ₹8.23 Cr for the quarter ended Sep 2026. Figures in ₹ crore, consolidated where available.
NEOGEN quarterly results (₹ Cr)
Metric
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Sales
201.43
202.82
186.73
208.66
220.02
246.56
250.29
295.96
Expenses
166.79
166.44
155.22
178.7
188.12
202.65
202.06
250.64
Operating Profit
34.64
36.38
31.51
29.96
31.9
43.91
48.23
45.32
OPM
17.2%
17.94%
16.87%
14.36%
14.5%
17.81%
19.27%
15.31%
Other Income
1.14
-13.44
1.23
1.98
2.2
1.01
4.06
3.97
Interest
13.43
12.5
12.67
19.48
21.51
21.47
20.81
27.78
Depreciation
7.1
6.76
5.78
7.31
6.83
7.6
8.2
8.79
Profit before tax
15.25
3.68
14.29
5.15
5.76
15.85
23.28
12.72
Tax
34.36%
34.51%
28.2%
34.56%
35.94%
28.14%
26.5%
35.3%
Net Profit
10.01
2.41
10.26
3.37
3.69
11.39
17.11
8.23
EPS in Rs
3.79
0.91
3.89
1.28
1.4
4.32
6.25
2.74
NEOGEN profit & loss, annual (₹ Cr)
Metric
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
TTM
Sales
487
686
691
778
862
1,013
Expenses
401
575
581
641
725
843
Operating Profit
87
112
110
136
137
169
OPM
18%
16%
16%
18%
16%
17%
Other Income
1
5
8
-10
6
11
Interest
19
29
42
48
75
92
Depreciation
12
16
23
28
28
31
Profit before tax
57
71
53
50
41
58
Tax
22%
30%
32%
31%
30%
-
Net Profit
45
50
36
35
29
40
EPS in Rs
17.9
20.04
13.51
13.2
10.9
14.71
Dividend Payout
15%
15%
15%
8%
18%
-
NEOGEN balance sheet (₹ Cr)
Metric
Mar 2024
Mar 2025
Sep 2025
Mar 2026
Sep 2026
Equity Capital
26
26
26
26
30
Reserves
734
763
773
790
1,547
Borrowings
409
597
1,132
1,395
1,641
Other Liabilities
292
361
370
691
787
Total Liabilities
1,461
1,747
2,302
2,902
4,005
Fixed Assets
496
404
426
475
626
CWIP
109
156
335
857
1,187
Investments
0
0
101
0
0
Other Assets
856
1,187
1,440
1,570
2,191
Total Assets
1,461
1,747
2,302
2,902
4,005
NEOGEN cash flows (₹ Cr)
Metric
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Cash from Operating Activity
1
-30
-29
196
-231
Cash from Investing Activity
-146
-94
-216
-317
-410
Cash from Financing Activity
188
100
237
113
642
Net Cash Flow
44
-25
-8
-8
0
Free Cash Flow
-65
-134
-332
-121
-647
CFO/OP
13%
-17%
-18%
153%
-154%
CFO/EBITDAShare of operating profit converting into cash: CFO (before tax) / Operating Profit